Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms

被引:34
作者
Heinrich, Daniel A. [1 ]
Adolf, Christian [1 ]
Rump, Lars C. [2 ]
Quack, Ivo [2 ]
Quinkler, Marcus [3 ]
Hahner, Stefanie [4 ]
Januszewicz, Andrzej [5 ]
Seufert, Jochen [6 ]
Willenberg, Holger S. [7 ]
Nirschl, Nina [1 ]
Sturm, Lisa [1 ]
Beuschlein, Felix [1 ,8 ]
Reincke, Martin [1 ]
机构
[1] LMU Munchen, Klinikum Univ, Med Klin & Poliklin 4, Munich, Germany
[2] Heinrich Heine Univ Dusseldorf, Dept Nephrol, Dusseldorf, Germany
[3] Endocrinol Charlottenburg, Berlin, Germany
[4] Univ Klinikum Wurzburg, Med Klin & Poliklin 1, Schwerpunkt Endokrinol & Diabetol, Wurzburg, Germany
[5] Inst Cardiol, Dept Hypertens, Warsaw, Poland
[6] Univ Freiburg, Fac Med, Med Ctr, Div Endocrinol & Diabetol, Freiburg, Germany
[7] Rostock Univ, Med Ctr, Div Endocrinol & Metab, Rostock, Germany
[8] Univ Spital Zurich, Klin Endokrinol Diabetol & Klin Ernahrung, Zurich, Switzerland
关键词
UNILATERAL PRIMARY ALDOSTERONISM; CLINICAL-PRACTICE GUIDELINE; GERMAN CONNS REGISTRY; HYPERTENSION; PREVALENCE; MANIFESTATIONS; OUTCOMES; CENTERS; EVENTS; EUROPE;
D O I
10.1530/EJE-17-0978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Primary aldosteronism (PA) is the most common endocrine form of arterial hypertension. The German Conn's Registry's purpose is to improve treatment outcomes of PA. We assessed whether key clinical, biochemical and epidemiological characteristics of newly diagnosed PA cases have changed over time, potentially indicating a different screening and referral practice in Germany evolving from 2008 to 2016. Design: The German Conn's Registry is a multicenter database prospectively analyzing morbidity and long-term outcome of patients with PA. Methods: Phenotypic changes between three year periods were calculated using Mann-Whitney U tests and Kruskal-WaIlls tests for independent variables. Results: Over three time periods from 2008 to 2016, we noted a relative decrease of unilateral PA cases (67 vs 43%). Significantly more females were diagnosed with PA (33 vs 43%). Median daily defined drug doses decreased (3.1 vs 2.0) in the presence of unchanged SBP (150 vs 1 50 mmHg), plasma aldosterone (199 vs 173 ng/L) and PRC (3.2 vs 3.2 U/L). Median ARR values decreased (70 vs 47 ng/U) and median potassium levels at diagnosis (3.5 vs 3.7 mmol/L) increased as the percentage of normokalemic patients (25 vs 41 %), indicating milder forms of PA. Conclusions: Our results are in accordance with an increased screening intensity for PA. We identified a trend toward diagnosing milder forms, increasingly more females and less unilateral cases of PA.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 28 条
[1]   Recent Developments in Primary Aldosteronism [J].
Asbach, E. ;
Williams, T. A. ;
Reincke, M. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2016, 124 (06) :335-341
[2]   Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study [J].
Banegas, Jose R. ;
Lopez-Garcia, Esther ;
Dallongeville, Jean ;
Guallar, Eliseo ;
Halcox, Julian P. ;
Borghi, Claudio ;
Masso-Gonzalez, Elvira L. ;
Jimenez, Francisco J. ;
Perk, Joep ;
Gabriel Steg, Philippe ;
De Backer, Guy ;
Rodriguez-Artalejo, Fernando .
EUROPEAN HEART JOURNAL, 2011, 32 (17) :2143-2152
[3]   Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates [J].
Betz, Matthias J. ;
Degenhart, Christoph ;
Fischer, Evelyn ;
Pallauf, Anna ;
Brand, Volker ;
Linsenmaier, Ulrich ;
Beuschlein, Felix ;
Bidlingmaier, Martin ;
Reincke, Martin .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (02) :301-306
[4]   Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn's Registry [J].
Born-Frontsberg, E. ;
Reincke, M. ;
Rump, L. C. ;
Hahner, S. ;
Diederich, S. ;
Lorenz, R. ;
Allolio, B. ;
Seufert, J. ;
Schirpenbach, C. ;
Beuschlein, F. ;
Bidlingmaier, M. ;
Endres, S. ;
Quinkler, M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04) :1125-1130
[5]   Cardiovascular outcomes in patients with primary aldosteronism after treatment [J].
Catena, Cristiana ;
Colussi, GianLuca ;
Nadalini, Elisa ;
Chiuch, Alessandra ;
Baroselli, Sara ;
Lapenna, Roberta ;
Sechi, Leonardo A. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) :80-85
[6]  
CONN JW, 1955, J LAB CLIN MED, V45, P661
[7]   Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline [J].
Funder, John W. ;
Carey, Robert M. ;
Fardella, Carlos ;
Gomez-Sanchez, Celso E. ;
Mantero, Franco ;
Stowasser, Michael ;
Young, William F., Jr. ;
Montori, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) :3266-3281
[8]   The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline [J].
Funder, John W. ;
Carey, Robert M. ;
Mantero, Franco ;
Murad, M. Hassan ;
Reincke, Martin ;
Shibata, Hirotaka ;
Stowasser, Michael ;
Young, William F., Jr. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (05) :1889-1916
[9]   Hypertension in women: latest findings and clinical implications [J].
Gudmundsdottir, Helga ;
Hoieggen, Aud ;
Stenehjem, Aud ;
Waldum, Bard ;
Os, Ingrid .
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2012, 3 (03) :137-146
[10]   Changes in the clinical manifestations of primary aldosteronism [J].
Kim, Sun Hwa ;
Ahn, Jae Hee ;
Hong, Ho Cheol ;
Choi, Hae Yoon ;
Kim, Yoon Jung ;
Kim, Nam Hoon ;
Yoo, Hye Jin ;
Kim, Hee Young ;
Seo, Ji A. ;
Kim, Nan Hee ;
Kim, Sin Gon ;
Choi, Kyung Mook ;
Baik, Sei Hyun ;
Choi, Dong Seop .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (02) :217-225